Kerry Group plc (Tralee, Ireland) has acquired Wellmune from Biothera Inc. (Eagan, MN), a natural food, beverage and supplement ingredient that is clinically proven to help strengthen the immune system.
“At Kerry, cutting-edge science and technology informs everything we help shape and create. The addition of Wellmune to our portfolio offers Kerry tremendous growth opportunities globally,” said Michael O’Neill, nutrition president of Kerry. “This natural immunity enhancer strengthens our nutrition and general wellness capabilities and complements our taste solutions for applications in food, beverages and supplements.”
“The combination of Biothera’s technology and Kerry’s leadership in R&D, nutritional science, and forward looking market insights, will advance the science of immune health and help create new and innovative food, beverages and supplements,” added Richard G. Mueller, CEO of Biothera. “Wellmune is a great fit for Kerry’s portfolio of science-based, nutritional ingredients.”
Wellmune is a 100 percent natural food, beverage, and supplement ingredient that strengthens the immune system, making it easier for consumers to be well and stay well. Backed by more than 10 clinical studies, this proprietary yeast beta 1,3/1,6 glucan has regulatory approval in major markets around the world. Products with Wellmune are available in more than 60 countries. Wellmune is patented, kosher, halal, non-allergenic, GMO (genetically modified organism)- and gluten free, as well as Informed-Sport Certified.
For more information, visit www.wellmune.com.
